Literature DB >> 18190663

Driving under the influence of cannabis: a 10-year study of age and gender differences in the concentrations of tetrahydrocannabinol in blood.

Alan W Jones1, Anita Holmgren, Fredrik C Kugelberg.   

Abstract

BACKGROUND: Delta(9)-Tetrahydrocannabinol (THC) is the major psychoactive constituent of cannabis and its various preparations. Increasing use of cannabis for recreational purposes has created a problem for road-traffic safety. This paper compares age, gender and the concentrations of THC in blood of individuals apprehended for driving under the influence of drugs (DUID) in Sweden, where a zero-tolerance law operates. MEASUREMENTS: Specimens of blood or urine were subjected to a broad screening analysis by enzyme immunoassay methods. THC positives were verified by analysis of blood by gas chromatography-mass spectrometry (GC-MS) with a deuterium-labelled internal standard (d(3)-THC). All toxicology results were entered into a database (TOXBASE) along with the age and gender of apprehended drivers.
FINDINGS: Over a 10-year period (1995-2004), between 18% and 30% of all DUID suspects had measurable amounts of THC in their blood (> 0.3 ng/ml) either alone or together with other drugs. The mean age [+/- standard deviation (SD)] of cannabis users was 33 +/- 9.4 years (range 15-66 years), with a strong predominance of men (94%, P < 0.001). The frequency distribution of THC concentrations (n = 8794) was skewed markedly to the right with mean, median and highest values of 2.1 ng/ml, 1.0 ng/ml and 67 ng/ml, respectively. The THC concentration was less than 1.0 ng/ml in 43% of cases and below 2.0 ng/ml in 61% of cases. The age of offenders was not correlated with the concentration of THC in blood (r = -0.027, P > 0.05). THC concentrations in blood were higher when this was the only psychoactive substance present (n = 1276); mean 3.6 ng/ml, median 2.0 ng/ml compared with multi-drug users; mean 1.8 ng/ml, median 1.0 ng/ml (P < 0.001). In cases with THC as the only drug present the concentration was less than 1.0 ng/ml in 26% and below 2.0 ng/ml in 41% of cases. The high prevalence of men, the average age and the concentrations of THC in blood were similar in users of illicit drugs (non-traffic cases).
CONCLUSIONS: The concentration of THC in blood at the time of driving is probably a great deal higher than at the time of sampling (30-90 minutes later). The notion of enacting science-based concentration limits of THC in blood (e.g. 3-5 ng/ml), as discussed in some quarters, would result in many individuals evading prosecution. Zero-tolerance or limit of quantitation laws are a much more pragmatic way to enforce DUID legislation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18190663     DOI: 10.1111/j.1360-0443.2007.02091.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  23 in total

1.  Cannabis and traffic collision risk: findings from a case-crossover study of injured drivers presenting to emergency departments.

Authors:  Mark Asbridge; Robert Mann; Michael D Cusimano; Cynthia Trayling; Michael Roerecke; John M Tallon; Alyce Whipp; Jürgen Rehm
Journal:  Int J Public Health       Date:  2013-09-24       Impact factor: 3.380

Review 2.  How important are sex differences in cannabinoid action?

Authors:  Liana Fattore; Walter Fratta
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

3.  Developing public health regulations for marijuana: lessons from alcohol and tobacco.

Authors:  Rosalie Liccardo Pacula; Beau Kilmer; Alexander C Wagenaar; Frank J Chaloupka; Jonathan P Caulkins
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

4.  Cannabis effects on driving lateral control with and without alcohol.

Authors:  Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; Russell S Pierce; David A Gorelick; Gary Gaffney; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2015-06-23       Impact factor: 4.492

Review 5.  Cannabis effects on driving skills.

Authors:  Rebecca L Hartman; Marilyn A Huestis
Journal:  Clin Chem       Date:  2012-12-07       Impact factor: 8.327

6.  Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws.

Authors:  Mateus M Bergamaschi; Erin L Karschner; Robert S Goodwin; Karl B Scheidweiler; Jussi Hirvonen; Regina H C Queiroz; Marilyn A Huestis
Journal:  Clin Chem       Date:  2013-03       Impact factor: 8.327

7.  Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships.

Authors:  Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; David A Gorelick; Gary Gaffney; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2015-08-10       Impact factor: 3.345

8.  Differences in state drug testing and reporting by driver type in U.S. fatal traffic crashes.

Authors:  Megan E Slater; I-Jen P Castle; Barry K Logan; Ralph W Hingson
Journal:  Accid Anal Prev       Date:  2016-04-06

9.  Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.

Authors:  Erin L Karschner; Eugene W Schwilke; Ross H Lowe; W David Darwin; Ronald I Herning; Jean Lud Cadet; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2009-10       Impact factor: 3.367

Review 10.  Sex differences in the cannabinoid regulation of energy homeostasis.

Authors:  Borzoo Farhang; Shanna Diaz; Stephanie L Tang; Edward J Wagner
Journal:  Psychoneuroendocrinology       Date:  2009-12       Impact factor: 4.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.